Efficacy of convalescent plasma therapy in improving survival in non-immunized COVID-19 patients
Abstract Purpose Convalescent plasma (CP), obtained from individuals who have recovered from COVID-19, has been widely explored as a potential therapeutic option, particularly in the absence of vaccines and monoclonal antibody treatments. This study aimed to evaluate the effectiveness of CP therapy...
Saved in:
Main Authors: | Tania Portella Costa, Dayanne Mozaner Bordin, Mateus Nóbrega Aoki, Lucas Blanes |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-06-01
|
Series: | Virology Journal |
Online Access: | https://doi.org/10.1186/s12985-025-02778-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of variable titer COVID-19 convalescent plasma and recipient SARS-CoV2-specific humoral immunity on survival in hospitalized patients.
by: Carlo J Iasella, et al.
Published: (2024-01-01) -
Effectiveness of Convalescent Plasma Therapy in Treating COVID-19: an Evidence-based Case Report
by: Mira Yulianti, et al.
Published: (2022-01-01) -
Sustained expression of inflammatory monocytes and activated T cells in COVID‐19 patients and recovered convalescent plasma donors
by: Ravinder Singh, et al.
Published: (2021-12-01) -
The effect of early COVID-19 treatment with convalescent plasma on antibody responses to SARS-CoV-2
by: Andy Kwan Pui Chan, et al.
Published: (2025-07-01) -
Dynamic electroencephalographic study of persons – mild COVID-19 convalescents
by: S. A. Gulyaev
Published: (2023-05-01)